Skip to main content

Table 1 The baseline characteristics of the samples

From: Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial

 

Phlebotomy

N = 27

OCs

N = 30

P-value*

Age, (y)

24 (4.06)

24.2 (5.2)

0.878

BMI, (kg/m2)

27.1 (5.04)

25.4 (5.3)

0.323

WHR,

0.8 (0.06)

0.7 (0.08)

0.223

HB, (g/dl)

14.1 (1.1)

14.3 (1.3)

0.166

HCT

40.4 (2.1)

39.6 (2.3)

0.330

Ferritin, (ng/mL)

74.2 (54.06)

48.5 (30.9)

0.070

SBP, (mm Hg)

102.3 (9.0)

100.2 (18.9)

0.526

DBP, (mm Hg)

67.6 (6.4)

66.2 (7.8)

0.503

Hirsutism score,

16.8 (6)

14.3 (7)

0.063

Acne, yes (%)

13 (74)

17 (56.6)

0.189

FAI, median

5.2 (1.6–12.8)

4.4 (1.4–4.7)

0.051

Total Testosterone, (ng/mL)

0.52 (0.3)

0.40 (0.1)

0.095

Androstenedione, (ng/mL)

4.7 (1.9)

4.1 (1.8)

0.350

SHBG, (nmol/L)

35.5 (20.9)

46.6 (46.8)

0.059

HOMA-IR, median

3.5 (1.3–4.5)

3.1 (1.4–3.5)

0.595

Insulin, (μU/mL)

9.5 (6.8–20)

10.8 (7.6–14.9)

0.626

GTT, fasting, (mg/dL)

84.3 (6.6)

83.8 (6.7)

0.813

GTT, 2 h, (mg/dL)

101.9 (12.7)

90.2 (23.9)

0.940

Cholesterol, (mg/dL)

178.5 (37.9)

178.7 (33.3)

0.985

Triglycerides, (mg/dL)

115.5 (107.9)

114.2 (48)

0.957

HDL-C, (mg/dL)

45.5 (15.1)

47.5 (10.3)

0.611

LDL-C, (mg/dL)

95.5 (26)

97.1 (22.7)

0.831

AMH, (ng/mL)

8.1 (6)

8.7 (6)

0.471

PSA, (ng/mL)

0.005 (0.002–0.009)

0.004 (0.002–0.020)

0.688

  1. *The statistical significance level was set at 0.05; Values are given as mean (standard deviation) or median (25–75%), as appropriate.
  2. BMI Body Mass Index; WHR Waist to Hip Ratio; HB Hemoglobin; HCT Hematocrit; SBP Systolic blood pressure; DBP Diastolic blood pressure; FAI Free Androgen Index; SHBG Sex Hormone Androgen Index; HOMA-IR Homeostatic Model Assessment for Insulin Resistance; GTT Glucose tolerance test; HDL High Density Lipoprotein; LDL Low Density Lipoprotein; AMH Anti Mullerian Hormone; PSA Prostate Specific Antigen.; SHBG Sex hormone-binding globulin; OCs oral contraceptives containing cyproterone acetate